Notice of Meeting, 29773 [2010-12544]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10 (d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b (c)(6). Grant
applications for the Recovery Act 2009
Limited Competition: Prospect
Studies—Building New Clinical
Infrastructure for CE (R01) applications
are to be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Recovery Act 2009
Limited Competition: Prospect Studies—
Building New Clinical Infrastructure for CE
(R01).
Dates: June 16, 2010. (Open on June 16
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting.)
Place: Hyatt Regency Hotel, 7400
Wisconsin Avenue, 1 Bethesda Metro Center,
Conference Room TBD, Bethesda, MD 20814.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–12546 Filed 5–26–10; 8:45 am]
wwoods2 on DSK1DXX6B1PROD with NOTICES
BILLING CODE 4160–90–M
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the OS ARRA:
Enhancing Registries for Quality
Improvement and Comparative
Effectiveness (RO 1) applications are to
be reviewed and discussed at this
meeting. These discussions are likely to
reveal personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: OS ARRA: Enhancing
Registries for Quality Improvement and
Comparative Effectiveness (R01).
Dates: June 18, 2010. (Open on June 18
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting.)
Place: Crowne Plaza Hotel, 3 Research
Court, Conference Room TBD, Rockville, MD
20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–12544 Filed 5–26–10; 8:45 am]
Agency for Healthcare Research and
Quality
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
VerDate Mar<15>2010
15:26 May 26, 2010
Jkt 220001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
29773
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Collaborative
Interdisciplinary Team Science—Nuclear
Receptors.
Date: June 10, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Robert Wellner, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 757, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452. (301) 594–4721.
rw175w@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Metabolic Disease
and Pregnancy.
Date: June 10, 2010.
Time: 3:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Carol J. Goter-Robinson,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452. (301)
594–7791.
goterrobinsonc@extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 75, Number 102 (Thursday, May 27, 2010)]
[Notices]
[Page 29773]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12544]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the OS ARRA: Enhancing Registries
for Quality Improvement and Comparative Effectiveness (RO 1)
applications are to be reviewed and discussed at this meeting. These
discussions are likely to reveal personal information concerning
individuals associated with the applications. This information is
exempt from mandatory disclosure under the above-cited statutes.
SEP Meeting on: OS ARRA: Enhancing Registries for Quality
Improvement and Comparative Effectiveness (R01).
Dates: June 18, 2010. (Open on June 18 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting.)
Place: Crowne Plaza Hotel, 3 Research Court, Conference Room
TBD, Rockville, MD 20852.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
Dated: May 13, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-12544 Filed 5-26-10; 8:45 am]
BILLING CODE 4160-90-M
